Curatis Holding AG operates as a pharmaceutical company. It is engaged in the acquisition, development and commercialization of innovative medicines for the prevention, diagnosis and treatment of rare and specialty care diseases. The company was founded by Gunter Graubach and is headquartered in Liestal, Switzerland.